Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer

Wakako Daido, Takeshi Masuda, Nobuki Imano, Naoko Matsumoto, Kosuke Hamai, Yasuo Iwamoto, Yusuke Takayama, Sayaka Ueno, Masahiko Sumii, Hiroyasu Shoda, Nobuhisa Ishikawa, Masahiro Yamasaki, Yoshifumi Nishimura, Shigeo Kawase, Naoki Shiota, Yoshikazu Awaya, Tomoko Suzuki, Soichi Kitaguchi, Kazunori Fujitaka, Yasushi Nagata, Noboru Hattori

Open source

DOI
10.3390/cancers14246236
Published
2022-12-17
Container
Cancers
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers14246236,
  title = {Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer},
  author = {Wakako Daido and Takeshi Masuda and Nobuki Imano and Naoko Matsumoto and Kosuke Hamai and Yasuo Iwamoto and Yusuke Takayama and Sayaka Ueno and Masahiko Sumii and Hiroyasu Shoda and Nobuhisa Ishikawa and Masahiro Yamasaki and Yoshifumi Nishimura and Shigeo Kawase and Naoki Shiota and Yoshikazu Awaya and Tomoko Suzuki and Soichi Kitaguchi and Kazunori Fujitaka and Yasushi Nagata and Noboru Hattori},
  year = {2022},
  journal = {Cancers},
  doi = {10.3390/cancers14246236},
  url = {https://doi.org/10.3390/cancers14246236}
}

RIS

TY  - JOUR
TI  - Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer
AU  - Wakako Daido
AU  - Takeshi Masuda
AU  - Nobuki Imano
AU  - Naoko Matsumoto
AU  - Kosuke Hamai
AU  - Yasuo Iwamoto
AU  - Yusuke Takayama
AU  - Sayaka Ueno
AU  - Masahiko Sumii
AU  - Hiroyasu Shoda
AU  - Nobuhisa Ishikawa
AU  - Masahiro Yamasaki
AU  - Yoshifumi Nishimura
AU  - Shigeo Kawase
AU  - Naoki Shiota
AU  - Yoshikazu Awaya
AU  - Tomoko Suzuki
AU  - Soichi Kitaguchi
AU  - Kazunori Fujitaka
AU  - Yasushi Nagata
AU  - Noboru Hattori
PY  - 2022
JO  - Cancers
DO  - 10.3390/cancers14246236
UR  - https://doi.org/10.3390/cancers14246236
ER  - 

APA

Daido, W., Masuda, T., Imano, N., Matsumoto, N., Hamai, K., Iwamoto, Y., Takayama, Y., Ueno, S., Sumii, M., Shoda, H., Ishikawa, N., Yamasaki, M., Nishimura, Y., Kawase, S., Shiota, N., Awaya, Y., Suzuki, T., Kitaguchi, S., Fujitaka, K., Nagata, Y., & Hattori, N. (2022). Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer. Cancers. https://doi.org/10.3390/cancers14246236

Source records